Lysyl Oxidase as a Serum Biomarker of Liver Fibrosis in Patients with Severe Obesity and Obstructive Sleep Apnea

STUDY OBJECTIVES: Obstructive sleep apnea (OSA) is associated with the progression of nonalcoholic fatty liver disease (NAFLD). We hypothesized that the hypoxia of OSA increases hepatic production of lysyl oxidase (LOX), an enzyme that cross-links collagen, and that LOX may serve as a biomarker of h...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Sleep
Główni autorzy: Mesarwi, Omar A., Shin, Mi-Kyung, Drager, Luciano F., Bevans-Fonti, Shannon, Jun, Jonathan C., Putcha, Nirupama, Torbenson, Michael S., Pedrosa, Rodrigo P., Lorenzi-Filho, Geraldo, Steele, Kimberley E., Schweitzer, Michael A., Magnuson, Thomas H., Lidor, Anne O., Schwartz, Alan R., Polotsky, Vsevolod Y.
Format: Artigo
Język:Inglês
Wydane: Associated Professional Sleep Societies, LLC 2015
Hasła przedmiotowe:
Lysyl Oxidase as a Biomarker of Liver Fibrosis in Severely Obese Patients with OSA
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4576332/
https://ncbi.nlm.nih.gov/pubmed/26085300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5665/sleep.5052
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy